Nonprogression of coronary artery atherosclerosis in homozygous familial hypercholesterolemia after 31 months of repetitive plasma exchange
- 1 March 1986
- journal article
- case report
- Published by Wiley in Clinical Cardiology
- Vol. 9 (3) , 115-119
- https://doi.org/10.1002/clc.4960090306
Abstract
The effects of plasma exchange performed every two weeks for 31 months in combination with diet and drug therapy were studied in a patient with receptor‐defective homozygous familial hypercholesterolemia. Coronary angiography performed three years prior to commencing plasma exchange was compared to angiography 31 months after starting the program. Comparison of the angiograms taken six years apart showed no progression of coronary atheroma in the main left coronary artery in which a 30% narrowing was originally seen. An internal mammary artery‐coronary artery bypass remained widely patent and showed no development of atherosclerosis. Plasma cholesterol levels were reduced 46% by plasma exchange, diet and drug compared to diet and drug alone. Achilles tendon xanthoma diminished significantly. It appears that plasma exchange combined with diet and drug therapy, while not producing regression of existing atheromatous lesions, does retard or prevent further progression.Keywords
This publication has 8 references indexed in Scilit:
- PROGRESSION OF ATHEROMA IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA DURING REGULAR PLASMA EXCHANGEThe Lancet, 1981
- Repetitive intermittent flow plasma exchange in patients with severe hypercholesterolemiaAtherosclerosis, 1981
- Plasma-Exchange Therapy of Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1980
- Assessment of long-term plasma exchange for familial hypercholesterolaemia.Heart, 1980
- Continuous flow plasma exchange in the treatment of homozygous familial hypercholesterolemiaThe American Journal of Medicine, 1978
- PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1975
- Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.Proceedings of the National Academy of Sciences, 1975
- PORTACAVAL SHUNT IN HYPERLIPOPROTEINqMIAThe Lancet, 1973